Clinical Trial Update: Efficacy and Safety of PMK-S005 in the Prevention of Recurrent Peptic Ulcer in Low-dose Aspirin Users [Phase 2]

View source ↗

Summary

Phase 2 trial assessing efficacy and safety of PMK-S005 to prevent recurrent peptic ulcers in low-dose aspirin users has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peptic Ulcer

Drugs mentioned

• PMK-S005

Snippet

Sponsor: PharmaKing | Conditions: Peptic Ulcer | Phase 2 | Status: COMPLETED